Retaglutide and tirzepatide are innovative GLP-1 receptor agonists gaining attention as effective treatment options for type 2 diabetes. These medications promote insulin secretion from the pancreas, reduce glucagon https://marcwfcn557105.activoblog.com/47657960/novel-agents-in-diabetes-management